Modality Solutions, A BlueRidge Life Sciences Company

Most cold chain cost conversations start with packaging spend and freight rates. But for advanced therapies, that framing misses where the real financial risk lives. ➡️ Swipe to see what actually drives cost in advanced therapy logistics, and how teams design systems that control both risk and spend. Learn more here: https://lnkd.in/gt7TcQMg #ModalitySolutions #AdvancedTherapies #ColdChain #BiopharmaLogistics #ClinicalSupplyChain #SupplyChainOptimization

Besmir Mucogllava designs the experiments that make cold chain regulatory submissions defensible. As a Senior Consulting Engineer at Modality Solutions, he tests how real-world shipping conditions affect product integrity across biologics, pharmaceuticals, and cell and gene therapies, and turns those findings into documentation that holds up under regulatory scrutiny. Learn more about Besmir: https://lnkd.in/gPMu56NY #ModalitySolutions #TeamSpotlight #ColdChain #TransportValidation #AdvancedTherapies #BiopharmaLogistics

Qualified vendors for advanced therapy programs are limited. Specialized testing labs, packaging providers, and logistics partners with the required handling capabilities are not interchangeable, and availability within a fixed timeline is never guaranteed. Modality Solutions, A BlueRidge Life Sciences Company sits at the center of this challenge, bringing the specialized capability, qualified partnerships, and contingency planning that advanced therapy programs require before they need it. Learn how we help advanced therapy programs address vendor constraints before they become program risks: https://lnkd.in/gU-_TAvw #ModalitySolutions #AdvancedTherapies #ColdChain #Validation #BiopharmaLogistics #RegulatoryCompliance #ClinicalSupplyChain

When you're managing temperature-sensitive materials with no recovery path, every gap in the supply chain carries real consequences. Yet, most cold chain systems weren't designed with that accountability in mind. This guide is built for teams who need their supply chain to perform when failure isn't an option and and includes practical frameworks for every stage of the cold chain: • Temperature management requirements for irreplaceable materials • Shelf life constraints and how they shape logistics decisions • Time-sensitive execution and what it demands operationally • Validation, stakeholder alignment, and building systems that hold under pressure → Swipe for a preview, then download your full copy here: https://lnkd.in/g2_cYc63 #ModalitySolutions #AdvancedTherapies #ColdChain #BiopharmaLogistics #ClinicalSupplyChain #SupplyChainOptimization

ADC supply chains require two sets of controls operating in parallel, not in sequence. The biologic component demands protection from temperature excursions, mechanical stress, and linker degradation. The cytotoxic payload requires containment, decontamination validation, and personnel safety protocols at every handoff. Neither track can be subordinated to the other. Programs that treat these as separate workstreams end up with gaps that only surface during audits or release failures. Read more about what ADC logistics requires: https://lnkd.in/gGvJhMZT #ModalitySolutions #ADC #BiopharmaLogistics #ColdChain #PharmaceuticalLogistics #Validation #LifeSciences #SupplyChainOptimization

Controlled rate freezing sits at the center of cell therapy manufacturing, yet there is no single standard for how it is done. That gap has consequences as programs scale and regulatory scrutiny increases. Modality Solution's Hrithik Basu and Eryn Castaneda, alongside Rui Li, Ph.D. of EastWind CryoWorks, explore the current state of CRF, the forces driving variability, and what triggers a change to an existing freezing process. It is a practical foundation for anyone involved in developing, scaling, or delivering cell-based therapies. Read the full article at the link below. #ModalitySolutions #CellTherapy #ClinicalSupplyChain #AdvancedTherapies #ColdChain #Validation #LifeSciences #GeneTherapy

The June edition of 𝘊𝘰𝘭𝘥 𝘊𝘩𝘢𝘪𝘯 𝘊𝘰𝘯𝘯𝘦𝘤𝘵𝘪𝘰𝘯𝘴 covers three areas where advanced therapy programs are most exposed: • How stability data shapes every downstream supply chain decision • What it takes to align CMC and quality systems with real execution timelines • What purpose-built logistics actually requires in cell and gene therapy programs. If any one of those elements isn't designed around the others, the consequences tend to surface at the worst possible moment. Check out the latest issue today. #ModalitySolutions #ColdChainConnections #AdvancedTherapies #ColdChain #CMC #GeneTherapy #CellTherapy #BiopharmaLogistics

⏱️ Speed and compliance are often treated as competing priorities in advanced therapy programs, but in reality, they’re not. When release testing runs in parallel with production and documentation is built into execution rather than added after, speed becomes a byproduct of a well-designed system. See how CMC and quality design support execution in advanced therapy programs: https://lnkd.in/gU-_TAvw #ModalitySolutions #AdvancedTherapies #ColdChain #Validation #BiopharmaLogistics #RegulatoryCompliance #ClinicalSupplyChain

Stability data touches every decision in an advanced therapy program. Packaging, routing, contingency planning, and deviation management all depend on understanding exactly how long the product holds up and under what conditions. When that data isn't integrated into supply chain design from the start, gaps show up at the worst possible moment. ➡️ Swipe to see how building stability into the system changes what's possible. Read more here: https://lnkd.in/gzHDrvMx #ModalitySolutions #AdvancedTherapies #ColdChain #Validation #PharmaceuticalLogistics #ClinicalSupplyChain

In CGT, when a therapy is collected from a specific patient, modified, and returned to that same patient, every handoff between apheresis centers, manufacturing sites, and clinical units has to be executed without error. A breakdown causes not only a logistics problem, but also a catastrophic clinical one. That level of precision requires more than careful shipping. It requires a fully integrated, validated system designed around the patient from collection to infusion. See what precision looks like across a CGT supply chain: https://lnkd.in/gqqKJE3z #ModalitySolutions #CellTherapy #GeneTherapy #AdvancedTherapies #ColdChain #ClinicalSupplyChain #BiopharmaLogistics #ChainOfIdentity